Impax Laboratories, Inc. Blog | Talkmarkets | Page 1
No data available
No data available
Latest Posts
1 to 9 of 9 Posts
3 Drug Stocks Poised To Surpass Estimates In Q2 Earnings
Article By: Zacks Investment Research Tuesday, August 8, 2017 2:32 PM EDT
The pharma/biotech sector has picked up pace this year after being battered by the drug pricing controversy in 2016. The first half has been pretty strong for companies in the space.
In this article: ALNY, IPXL, PBYI Also: JNJ, LLY, MRK, NVS, AMGN, BIIB, CELG, TEVA, ABBV
Read
AstraZeneca Enters Agreement With Grunenthal To Divest Rights To Zomig
Article By: The Fly Wednesday, June 7, 2017 12:10 PM EDT
AstraZeneca announced that it has entered an agreement with Grunenthal for the global rights to Zomig outside Japan.
In this article: AZN, IPXL
Read
Today's Stock Watch List - Friday, April 28
Article By: Ryan Mallory Friday, April 28, 2017 12:02 PM EDT
Today's stock watch list includes: CY, IPXL and CBS.
In this article: CBS, CY, IPXL
Read
Ex-CEO And Chairman Of Allergan, Paul Bisaro, Is Taking The Helm At Impax Laboratories Inc
Article By: Lorimer Wilson Tuesday, March 28, 2017 8:14 AM EDT
After handing over both the CEO and chairman reins at the company now known as Allergan longtime generics chief, Paul Bisaro, is taking the helm at Impax Laboratories Inc.
In this article: AGN, IPXL Also: NVS, TEVA, ABT, MYL
Read
Generic Drugs Probe Seen As Possible 'Severe' Sector Overhang
Article By: The Fly Friday, November 4, 2016 1:40 PM EDT
Shares of several companies believed to be involved in the probe are recouping part of yesterday's losses.
In this article: TEVA, MYL, LCI, IPXL, ENDP, TARO
Read
S&P 500 Index Posted Its 8th Consecutive Loss
Article By: Marvin R Clark Friday, November 4, 2016 12:30 AM EDT
On Wednesday, the S&P 500 index posted its 7th consecutive loss; that has only happened 4 times in the last 20 years. Yesterday the market made it 8 in a row, matching the longest losing streak.
In this article: AGN, DDD, PRX, LCI, IPXL, MYL, TEVA, WYNN, WFM, OILB, USO, TARO, FB, ACT, FIT
Read
T2108 Update – Still Waiting For Volatility’s Moment
Article By: Dr. Duru Tuesday, September 6, 2016 4:04 AM EDT
Along with the plunge in volatility, the S&P 500 gapped back into the middle of the current trading range. The move left behind two straight days where sellers seemed to be ready to break the index down.
In this article: CORN, ADMP, USCR, DATA, IBB, IPXL, MYL, SPY, TWTR, VIX
Read
Pfizer's Breast Cancer Drug Ibrance Wins Early FDA Nod
Article By: Zacks Investment Research Tuesday, February 3, 2015 11:42 PM EDT
Pfizer Inc.’s (PFE) breast cancer drug, Ibrance received accelerated approval from the FDA to be used in combination with Novartis’ (NVS) Femara.
In this article: PFE, NVS, IPXL, AGN
Read
Insider Trading Report Edition #203: Notable Buys And Sales
Article By: Asif Suria Monday, May 12, 2014 6:10 AM EDT
Welcome to edition 203 of Insider Weekends. Insider buying bounced back last week with insiders purchasing $65.72 million of their stock compared to $16.74 million in the week prior.
In this article: ELX, GEO, HOS, OPK, TYC, IPXL, CHTR, CLMS, COLM, MSFT, MBRG, FB
Read
1 to 9 of 9 Posts